BioM and Munich Biotech Cluster celebrate its 25th anniversary

A quarter century of success in biotechnology

01-Aug-2022 - BioM and the Munich Biotech Cluster celebrated their 25th anniversary. Together, they can claim a great success story. With the support of the biotech cluster management organization, the life science region has become one of the most successful biotech hotspots in Europe. At the celebration ...

Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

05-Mar-2019 - Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for ...

Opening the way for global innovation in biotechnology

New agreement supports sharing, innovation and openness

16-Oct-2018 - A new easy-to-use legal tool that enables open exchange of biological materials is launched. The OpenMTA is a Material Transfer Agreement (MTA) designed to support openness, sharing and innovation in global biotechnology. Material Transfer Agreements (MTAs) provide the legal frameworks within ...

EPA to Grant Merck’s Patent Application for CRISPR Technology

Related patent application recently awarded in Australia

04-Aug-2017 - Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technology ...

Merck awarded its first CRISPR patent by Australian Patent Office

15-Jun-2017 - Merck announced that the Australian Patent Office has granted the company patent rights over the use of CRISPR in a genomic integration method for eukaryotic cells. The patent is the first that Merck, a leader in genome editing, has received for CRISPR technology. The patent covers chromosomal ...

Future of regenerative medicine looks bright with new funding boost

04-Apr-2017 - The UK Regenerative Medicine Platform (UKRMP), is to receive a further multimillion funding commitment to help realise the goal of accelerating scientific discoveries in regenerative therapies to clinical application. The Platform is a joint initiative between the Medical Research Council (MRC), ...

Updating embryo research guidelines

21-Nov-2016 - With advancing lab technology perhaps calling into question a longstanding guideline that prohibits experimentation on human embryos older than 14 days, scientists and ethicists gathered at Harvard Law School recently to discuss whether and how that stricture should be revised. Some speakers at ...

New Standards in Biotechnology

26-May-2015 - A new working group for data processing and integration in biotechnology has been set up by the International Organization for Standardization, ISO. The working group aims to define consistent standards for the formatting, transfer and integration of life science data and models. The working ...

Genetically Modified Humans? Seven Reasons to Say “No”

15-May-2015 - Researchers at Sun Yat-sen University in Guangzhou, China published a paper on April 18, 2015, detailing the first use of the “gene editing” technology CRISPR in human embryos. The news initiated a global media firestorm about the irresponsibility of attempting to create genetically modified ...

From Promise to Productivity: Smart Policy for Sustainable EU Growth Through Biobased Products and Industrial Biotechnology

15-Oct-2012 - EuropaBio warmly welcomes the European Commission’s new proposal on industrial policy for growth and economic recovery. Launched by Vice President Tajani, following extensive consultation and analysis, the Communication builds on the work of the Lead Market Initiative (LMI) and highlights ...